This analysis of the proposed Medical Device User Fee & Modernization Act looks at areas in the bill that deal with speeding up the premarket review process, funding, third-party issues and patient safety. One member of the House subcommittee charged with overseeing reauthorization of the user fee has suggested that some of the money be allotted for post-market surveillance to enhance safety.

Related Summaries